PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression von Jiao, Shiping, Xia, Weiya, Yamaguchi, Hirohito, Wei, Yongkun, Chen, Mei-Kuang, Hsu, Jung-Mao, Hsu, Jennifer L, Yu, Wen-Hsuan, Du, Yi, Lee, Heng-Huan, Li, Chia-Wei, Chou, Chao-Kai, Lim, Seung-Oe, Chang, Shih-Shin, Litton, Jennifer, Arun, Banu, Hortobagyi, Gabriel N, Hung, Mien-Chie

Volltext

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian von Mersch, Jacqueline, Jackson, Michelle A, Park, Minjeong, Nebgen, Denise, Peterson, Susan K, Singletary, Claire, Arun, Banu K, Litton, Jennifer K

Volltext

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial von Diéras, Véronique, Han, Hyo S, Kaufman, Bella, Wildiers, Hans, Friedlander, Michael, Ayoub, Jean-Pierre, Puhalla, Shannon L, Bondarenko, Igor, Campone, Mario, Jakobsen, Erik H, Jalving, Mathilde, Oprean, Cristina, Palácová, Marketa, Park, Yeon Hee, Shparyk, Yaroslav, Yañez, Eduardo, Khandelwal, Nikhil, Kundu, Madan G, Dudley, Matthew, Ratajczak, Christine K, Maag, David, Arun, Banu K

Volltext

BRCA mutation genetic testing implications in the United States von Bayraktar, Soley, Arun, Banu

Volltext

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility von Robson, Mark E, Bradbury, Angela R, Arun, Banu, Domchek, Susan M, Ford, James M, Hampel, Heather L, Lipkin, Stephen M, Syngal, Sapna, Wollins, Dana S, Lindor, Noralane M

Volltext

ASO Author Reflections: Other Cancers in Patients with Breast Cancer Who Undergo Germline Testing von Murphy, Brittany L., Arun, Banu K.

Volltext

Helping Patients Understand and Cope with BRCA Mutations von Makhnoon, Sukh, Arun, Banu, Bedrosian, Isabelle

Volltext

Hematologic malignancies in Li–Fraumeni syndrome: A case report von Bundrant, Bethany, Gerstein, Yoheved, Arun, Banu, DiNardo, Courtney D.

Volltext

Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer von ATCHLEY, Deann P, ALBARRACIN, Constance T, LOPEZ, Adriana, VALERO, Vicente, AMOS, Christopher I, GONZALEZ-ANGULO, Ana Maria, HORTOBAGYI, Gabriel N, ARUN, Banu K

Volltext

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant von Litton, Jennifer K., Scoggins, Marion E., Hess, Kenneth R., Adrada, Beatriz E., Murthy, Rashmi K., Damodaran, Senthil, DeSnyder, Sarah M., Brewster, Abenaa M., Barcenas, Carlos H., Valero, Vicente, Whitman, Gary J., Schwartz-Gomez, Jill, Mittendorf, Elizabeth A., Thompson, Alastair M., Helgason, Thorunn, Ibrahim, Nuhad, Piwnica-Worms, Helen, Moulder, Stacy L., Arun, Banu K.

Volltext

miRacle of microRNA-Driven Cancer Nanotherapeutics von Kara, Goknur, Arun, Banu, Calin, George A, Ozpolat, Bulent

Volltext

What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open‐ended survey responses von Brown, Kerri, Ponton, Marisel, Davidson, Elenita, Arun, Banu, Volk, Robert J., Shete, Sanjay, Peterson, Susan K., Makhnoon, Sukh

Volltext

Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer von Jain, Shalini, Wang, Xiao, Chang, Chia-Chi, Ibarra-Drendall, Catherine, Wang, Hai, Zhang, Qingling, Brady, Samuel W, Li, Ping, Zhao, Hong, Dobbs, Jessica, Kyrish, Matt, Tkaczyk, Tomasz S, Ambrose, Adrian, Sistrunk, Christopher, Arun, Banu K, Richards-Kortum, Rebecca, Jia, Wei, Seewaldt, Victoria L, Yu, Dihua

Volltext

Inflammatory breast cancer: a proposed conceptual shift in the UICC–AJCC TNM staging system von Fouad, Tamer M, MD, Barrera, Angelica M Gutierrez, MS, Reuben, James M, PhD, Lucci, Anthony, MD, Woodward, Wendy A, MD, Stauder, Michael C, MD, Lim, Bora, MD, DeSnyder, Sarah M, MD, Arun, Banu, MD, Gildy, Babiera, MD, Valero, Vicente, MD, Hortobagyi, Gabriel N, MD, Ueno, Naoto T, Dr

Volltext

Clinical practice guidelines for BRCA1 and BRCA2 genetic testing von Pujol, Pascal, Barberis, Massimo, Beer, Philp, Friedman, Eitan, Piulats, Josep M., Capoluongo, Ettore D., Garcia Foncillas, Jesus, Ray-Coquard, Isabelle, Penault-Llorca, Frédérique, Foulkes, William D., Turnbull, Clare, Hanson, Helen, Narod, Steven, Arun, Banu K., Aapro, Matti S., Mandel, Jean-Louis, Normanno, Nicola, Lambrechts, Diether, Vergote, Ignace, Anahory, Michèle, Baertschi, Bernard, Baudry, Karen, Bignon, Yves-Jean, Bollet, Marc, Corsini, Carole, Cussenot, Olivier, De la Motte Rouge, Thibault, Duboys de Labarre, Marie, Duchamp, Florence, Duriez, Clarisse, Fizazi, Karim, Galibert, Virginie, Gladieff, Laurence, Gligorov, Joseph, Hammel, Pascal, Imbert-Bouteille, Marion, Jacot, William, Kogut-Kubiak, Tatiana, Lamy, Pierre-Jean, Nambot, Sophie, Neuzillet, Yann, Olschwang, Sylviane, Rebillard, Xavier, Rey, Jean-Marc, Rideau, Chloé, Spano, Jean-Philippe, Thomas, Frédéric, Treilleux, Isabelle, Vandromme, Marion, Vendrell, Julie, Vintraud, Michèle, Zarca, Daniel, Hughes, Kevin S., Alés Martínez, Jose E.

Volltext

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial von Tutt, Andrew, Dr, Robson, Mark, MD, Garber, Judy E, MD, Domchek, Susan M, MD, Audeh, M William, MD, Weitzel, Jeffrey N, Prof, Friedlander, Michael, Prof, Arun, Banu, Prof, Loman, Niklas, MD, Schmutzler, Rita K, Prof, Wardley, Andrew, MD, Mitchell, Gillian, MD, Earl, Helena, PhD, Wickens, Mark, BSc, Carmichael, James, Prof

Volltext

Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer von GONZALEZ-ANGULO, Ana M, TIMMS, Kirsten M, HORTOBAGYI, Gabriel N, DO, Kim-Anh, MILLS, Gordon B, MERIC-BERNSTAM, Funda, SHUYING LIU, HUIQIN CHEN, LITTON, Jennifer K, POTTER, Jennifer, LANCHBURY, Jerry S, STEMKE-HALE, Katherine, HENNESSY, Bryan T, ARUN, Banu K

Volltext

Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan von Abdel-Razeq, Hikmat, Al-Omari, Amal, Zahran, Farah, Arun, Banu

Volltext

Validation of a personalized risk prediction model for contralateral breast cancer von Chowdhury, Marzana, Euhus, David, Arun, Banu, Umbricht, Chris, Biswas, Swati, Choudhary, Pankaj

Volltext

Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing von Murphy, Brittany L., Yi, Min, Arun, Banu K., Gutierrez Barrera, Angelica M., Bedrosian, Isabelle

Volltext